Consistent with these findings, we showed here for the first time that increased production of FGF-2 by IM-treated GIST cells reflecting the activation of the FGF-2/FGFR autocrine loop can serve as a mechanism maintaining the aggressive behavior of IM-resistant tumor cells through the facilitation of their migration and invasion. The gene discussed is FGF2; the disease is neoplasm.